Enterobacteriaceae bacteremias among cancer patients: An observational cohort study

International Journal of Infectious Diseases

Volumn 17, Issue 6, 2013, Pages

  Henao Martínez, Andrés F ^a   González Fontal, Guido R ^b   Castillo Mancilla, José R ^a   Yang, Ivana V ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSIDAD MILITAR NUEVA GRANADA   (Colombia)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Cancer; Enterobacteriaceae; Klebsiella pneumoniae

Indexed keywords

AMINOPENICILLIN;

ADULT; AGED; APACHE; ARTICLE; BACTEREMIA; BIVARIATE ANALYSIS; CANCER PATIENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG EXPOSURE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE BACTEREMIA; FEMALE; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL PARAMETERS; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; POPULATION RESEARCH; THROMBOCYTE COUNT;

ADULT; AGED; BACTEREMIA; COHORT STUDIES; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS;

EID: 84877157963     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.11.030     Document Type: Article

References (18)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
2. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
3. Feld R. Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 2008, 32(Suppl 1):S30-S33.
4. Danai P.A., Moss M., Mannino D.M., Martin G.S. The epidemiology of sepsis in patients with malignancy. Chest J 2006, 129:1432-1440.
5. Hurwitz A.A., Watkins S.K. Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother 2012, 61:289-293.
6. Garcia de la Torre M., Romero-Vivas J., Martinez-Beltran J., Guerrero A., Meseguer M., Bouza E. Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis 1985, 7:143-150.
7. Wang L.S., Lee F.Y., Cheng D.L., Liu C.Y., Hinthorn D.R., Jost P.M. Klebsiella pneumoniae bacteremia: analysis of 100 episodes. J Formos Med Assoc 1990, 89:756-763.
8. Meatherall B.L., Gregson D., Ross T., Pitout J.D., Laupland K.B. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009, 122:866-873.
9. Tsay R.W., Siu L.K., Fung C.P., Chang F.Y. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med 2002, 162:1021-1027.
10. Geerdes H.F., Ziegler D., Lode H., Hund M., Loehr A., Fangmann W., Wagner J. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin Infect Dis 1992, 15:991-1002.
11. Boleij A., van Gelder M.M., Swinkels D.W., Tjalsma H. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011, 53:870-878.
12. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603.
13. Johanson W.G., Pierce A.K., Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of Gram-negative bacilli. N Engl J Med 1969, 281:1137-1140.
14. Lautenbach E., Han J., Santana E., Tolomeo P., Bilker W.B., Maslow J. Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in long-term care facility residents. Infect Control Hosp Epidemiol 2012, 33:302-304.
15. Bodey G.P., Elting L.S., Rodriquez S., Hernandez M. Klebsiella bacteremia. A 10-year review in a cancer institution. Cancer 1989, 64:2368-2376.
16. Kang C.I., Kim S.H., Bang J.W., Kim H.B., Kim N.J., Kim E.C., et al. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci 2006, 21:816-822.
17. Haeggman S., Lofdahl S., Burman L.G. An allelic variant of the chromosomal gene for class A beta-lactamase K2, specific for Klebsiella pneumoniae, is the ancestor of SHV-1. Antimicrob Agents Chemother 1997, 41:2705-2709.
18. Tadesse D.A., Zhao S., Tong E., Ayers S., Singh A., Bartholomew M.J., et al. Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis 2012, 18:741-749.